CA-CHARGEPOINT
19.6.2024 09:01:31 CEST | Business Wire | Press release
ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), today announced a suite of updates and additions to its be.ENERGISED platform, a leading European software solution for the management of charging networks and e-mobility services at scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619736580/en/
(Photo: Business Wire)
be.ENERGISED now manages over 900 models of charging stations from more than 100 manufacturers. New features, offerings and enhancements include:
- The first payment terminal to meet the new OCPI v2.2.1 Direct Payment Module industry standards and comply with the recently instated AFIR (Alternative Fuel Infrastructure Regulation).
- eMobility Service Providers (eMSPs) can use the solutions’ roaming network to give their drivers selected access to more than 750,000 stations across the whole of Europe. Charge Point Operators (CPOs) can easily make their stations available to the public and all drivers on the major eMSPs via be.ENERGISED COMMUNITY roaming agreements in just a few clicks of a mouse.
- In addition, the CP6000 - ChargePoint’s most flexible and serviceable global AC EV charging solution - is available from this week on the be.ENERGISED platform to select customers. The CP6000 is designed for scalability, flexibility, and reliability, offering reliable AC charging for 1 or 3 phase power at an adaptable output of 3.7 to 22kw per port.
ChargePoint’s be.ENERGISED platform boasts consolidated services for CPOs and eMSPs, including VAT handling, automated invoicing, streamlining financial operations for multinational charging providers. With over 85,000 charging ports and 30 million charging sessions per month, be.ENERGISED’s scale and experience are unparalleled in the industry. The software offers an end-to-end solution capable of addressing every aspect of the charging process, providing unmatched flexibility and modularity to cater to all use cases.
The EV charging landscape is rapidly evolving, with CPOs and eMSPs becoming far more sophisticated, often relying on many makes of chargers and hundreds of software integrations with partners. As their expertise deepens, so do their needs, transforming from initial solutions into intricate networks which require robust protection and management. This shift signifies a move from the early days of greenfield projects to the current “brownfield” environment, where existing charger investments must be futureproofed alongside the implementation of new infrastructure. Though new chargers are constantly being brought online, ensuring a reliable network requires legacy hardware running just as well as the newest installations. All of this underscores the need for a well-rounded, adaptable software solution such as be.ENERGISED.
“A new set of market demands necessitates even the most advanced charger management platforms to deliver innovative features for the future,” said Andreas Blin, Director for Service Provision at ChargePoint. “A leader in the market for more than a decade, be.ENERGISED meets the challenges charging businesses face, ensuring that both new and existing infrastructure can excel in an ever more dynamic environment.”
Since acquiring be.ENERGISED three years ago, ChargePoint has continued to foster and develop the product to ensure market leadership while delivering bespoke solutions for international customers. be.ENERGISED is now the most flexible and comprehensive solution on the market, and one built for the future without forgetting about the past.
To learn more about ChargePoint’s be.ENERGISED platform, please click here or visit the ChargePoint stand B6.111Hall B6 at the Power2Drive charging infrastructure exposition in Munich held June 19-21st.
About ChargePoint Holdings, Inc.
ChargePoint is creating a new fuelling network to move people and goods on electricity. Since 2007, ChargePoint has been committed to making it easy for businesses and drivers to go electric with one of the largest EV charging networks and a comprehensive portfolio of charging solutions. The ChargePoint cloud subscription platform and software-defined charging hardware are designed to include options for every charging scenario from home and multifamily to workplace, parking, hospitality, retail, and transport fleets of all types. Today, one ChargePoint account provides access to hundreds-of-thousands of places to charge in North America and Europe. For more information, visit the ChargePoint pressroom, the ChargePoint Investor Relations site, or contact the ChargePoint North American or European press office or Investor Relations.
CHPT-IR
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240619736580/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
